The Vistria Group acquires BioCare
Partnership further increases investment firm’s repertoire in healthcare space
The Vistria Group, LP, a private investment firm, has acquired BioCare, Inc., a specialty pharma distribution partner that provides distribution, specialty pharmacy and logistics services. BioCare is The Vistria Group’s first investment from Vistria Fund IV, LP, a $2.68 billion fund, which closed this past June.
BioCare, Inc. includes BioCareSD, a specialty distributor of therapies, LogiCare3PL, a provider of time and temperature-sensitive pharmaceutical logistics services and CanyonCareRX, a full-service specialty pharmacy. The company partners with blue-chip manufacturers, connecting them to healthcare providers from hospitals, specialty pharmacies, ambulatory infusion centers, physician infusion suites and other alternate site locations.
“Today’s announcement marks an exciting path forward for BioCare. Partnering with The Vistria Group will allow us to invest additional resources to better serve our customers and reach more patients who suffer from rare, ultra-rare and orphan diseases,” says Linda Matthews, CEO of BioCare.
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
